You are browsing in:
Tag: NSAID
Cat sitting on owner's lap

2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats

Taylor, S., Gruen, M., KuKanich, K., Lascelles, B.D.X., Monteiro, B.P., Sampietro, L.R., Robertson, S. and Steagall, P.V. | Journal of Feline Medicine and Surgery | April 2024
The aim of these consensus guidelines is to provide veterinary practitioners with information on the appropriate use of non-steroidal anti-inflammatory drugs in the management of chronic pain in cats…

Efficacy and safety of enflicoxib for treatment of canine osteoarthritis

| Veterinary Record | 2021 | The objective of this prospective randomised controlled trial was to confirm the safety and efficacy of enflicoxib for the treatment of naturally occurring osteoarthritis (OA) in dogs …

Evaluation of the use of ketoprofen for the treatment of digital dermatitis in dairy cattle: A randomised, positive controlled, clinical trial

K. Kasiora, A. Anagnostopoulos, C. Bedford, T. Menka, M. Barden, B.E. Griffiths, D. Achard, K. Timms, V. Silva Machado, A. Coates and G. Oikonomou | Veterinary Record | October 2021
The objective of this randomised, positively controlled study was to evaluate the potential benefits of ketoprofen in cows with active digital dermatitis (DD)…

Efficacy and safety of enflicoxib for treatment of canine osteoarthritis: A 6-week randomised, controlled, blind, multicentre clinical trial

M. Salichs, L. Badiella, P. Sarasola and J. Homedes | Veterinary Record | September 2021
The aim of this prospective randomised controlled trial was to confirm the safety and efficacy of enflicoxib for the treatment of naturally occurring osteoarthritis (OA) in dogs…

A prospective, randomized, placebo-controlled, double-blinded clinical trial comparing the incidence and severity of gastrointestinal adverse events in dogs with cancer treated with piroxicam alone or in combination with omeprazole or famotidine

| Journal of the American Veterinary Medical Association | 2021 | The aim of this randomised placebo-controlled, double-blinded trial was to assess the impact of prophylactic administration of omeprazole or famotidine on the incidence and severity of gastrointestinal adverse events in dogs with cancer treated with piroxicam …

A prospective, randomized, placebo-controlled, double-blinded clinical trial comparing the incidence and severity of gastrointestinal adverse events in dogs with cancer treated with piroxicam alone or in combination with omeprazole or famotidine

M.H. Shaevitz, G.E. Moore and C.M. Fulkerson | Journal of the American Veterinary Medical Association | August 2021
The aim of this randomised placebo-controlled, double-blinded trial, which was carried at a Veterinary Teaching Hospital in the United States and funded by the Veterinary Cancer Society’s Resident Research Award, was to assess the impact of prophylactic administration of omeprazole or famotidine on the incidence and severity of gastrointestinal (GI) adverse events (AEs) in dogs with cancer treated with piroxicam…